Amendments Set to Clear Ambiguity
Pharmaceutical Technology
JUNE 22, 2008
Pharmaceutical companies dealing with the US will be closely watching the debate surrounding a proposed revision by the Senate which could see the watering down of some requirements, and an increase in others, under its Physician Payments Sunshine Act (S.2029). The benefits for the industry of adhering to the Act should not be overlooked.
Let's personalize your content